Vertex Pharmaceuticals Receives FDA Acceptance For Its Biologics License Application Submission For Povetacicept To Treat Immunoglobulin A Nephropathy

뉴스 본문을 불러오고 있어요.

Vertex Pharmaceuticals Receives FDA Acceptance For Its Biologics License Application Submission For Povetacicept To Treat Immunoglobulin A Nephropathy | 웨이프 WAPE

Vertex Pharmaceuticals Receives FDA Acceptance For Its Biologics License Application Submission For Povetacicept To Treat Immunoglobulin A Nephropathy

기사 요약

관련 종목

댓글 —